118th Congress · SENATE BILLBILL

S. 3733Shandra Eisenga Human Cell and Tissue Product Safety Act

A bill to require the Secretary of Health and Human Services to conduct a national, evidence-based education campaign to increase public and health care provider awareness regarding the potential risks and benefits of human cell and tissue products transplants, and for other purposes.

Health
Introduced Feb 5, 2024
Last action Feb 5, 2024
Pipeline · Bill → Law
Step 1
Introduced
Feb 5, 2024
Step 2
Referred
Feb 5, 2024
HELP
Step 3
Committee
Step 4
Senate
Step 5
House floor
Step 6
Resolve Changes
Step 7
Signed
SummaryCRS Summary

This bill requires the Department of Health and Human Services (HHS) to educate the public and health care providers about the benefits and risks of transplants that use human cell or tissue products, including the risk of infections. HHS must develop the educational campaign after taking into consideration information about products that carry the highest risk of transmitting infections to transplant recipients. HHS may award grants to other entities to conduct public awareness initiatives and media campaigns about the risk of infections.  The bill also establishes specific civil penalties for violations of laws regarding the spread of communicable diseases and regulations regarding proce...

Provisions · 6 sectionsIntroduced in Senate
Timeline · 2 actions
Feb 5, 2024
Introduced in Senate
Feb 5, 2024
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.